Skip to main content
رجوع
PRTA logo

Prothena Corporation plc

جودة البيانات: 100%
PRTA
NASDAQ Healthcare Biotechnology
KWD 9.31
▲ KWD 0.58 (6.64%)
القيمة السوقية: 501.19M
نطاق اليوم
KWD 8.84 KWD 9.31
نطاق 52 أسبوعًا
KWD 4.32 KWD 13.71
حجم التداول
543,662
متوسط 50 يوم / 200 يوم
KWD 9.16 / KWD 8.69
الإغلاق السابق
KWD 8.73

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -2.1 0.2
P/B 1.8 3.0
ROE % -63.6 3.6
Net Margin % -2520.6 3.8
Rev Growth 5Y % -53.1 9.9
D/E 0.1 0.2

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue declined -53.12% annually over 5 years
Debt/Equity of 0.05 — conservative balance sheet
Negative free cash flow of -163.72M
Revenue growth is decelerating — 1Y growth trails 5Y average by 39.71%
Capital efficient — spends only 1.43% of revenue on capex

النمو

Revenue Growth (5Y)
-53.12%
Revenue (1Y)-92.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-63.62%
ROIC-47.03%
Net Margin-2520.57%
Op. Margin-1905.82%

الأمان

Debt / Equity
0.05
Current Ratio7.72
Interest Coverage0.00

التقييم

P/E Ratio
-2.05
Forward P/EN/A
P/B Ratio1.79
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -92.83% Revenue Growth (3Y) -67.44%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -53.12% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 9.68M Net Income (TTM) -244.09M
ROE -63.62% ROA -74.69%
Gross Margin 61.77% Operating Margin -1905.82%
Net Margin -2520.57% Free Cash Flow (TTM) -163.72M
ROIC -47.03% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.05 Current Ratio 7.72
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.05 Forward P/E N/A
P/B Ratio 1.79 P/S Ratio 51.75
PEG Ratio -0.02 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32.67%
Market Cap 501.19M Enterprise Value 207.51M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 9.68M 135.16M 91.37M 53.91M 200.58M
Net Income -244.09M -122.31M -147.03M -116.95M 66.98M
EPS (Diluted) -4.53 -2.27 -2.76 -2.47 1.38
Gross Profit 5.98M 135.16M 91.37M 53.91M 200.58M
Operating Income -184.56M -154.56M -191.04M -131.56M 71.98M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 326.80M 547.11M 696.38M 758.04M 609.37M
Total Liabilities 46.33M 60.18M 135.02M 135.99M 143.32M
Shareholders' Equity 280.47M 486.93M 561.37M 622.04M 466.04M
Total Debt 13.86M 10.84M 11.84M 6.47M 12.33M
Cash & Equivalents 307.53M 471.39M 618.83M 710.41M 579.09M
Current Assets 315.19M 485.41M 639.28M 719.10M 584.81M
Current Liabilities 40.84M 48.50M 56.89M 50.15M 33.45M